The UNI Health Corporation mission is to forward scientific innovation and healthcare access by forging complementary industry partnerships.
We have partnered with the Peixe Rosa initiative to forward that mission to bring expanded research, development, production and distribution of medicine to South America.
Since 2009 the Peixe Rose initiative has been operated as a Clinical Research Organization (CRO). This program is an alliance of public/private partnerships operating mostly in Brazil.
Significantly cheaper R&D than in western nations
Access to the large Brazilian and Continental MERCOSUR market
Brazil has made it easy and cost effective to join this initiative
Partnerships forming one of the largest research alliances in the world.
Validation and scalability into Eurozone market
Protect your Investment with IP partnership with Cayman Islands
As a result of the COVID-19 Pandemic the organizers of the CRO temporarily lost access to facilities from alliance institutions causing research to halt thus requiring the creation of a medical research park for more autonomy.
The initiative is focused on meeting the underserved needs for medicine in Brazil by expanding research, production and healthcare services.
Pharmaceutical Market
Market Opportunity*
*We have assessed the Brazilian Pharmaceutical industry dependence on imported API as an issue of strategic national importance to the Brazilian Government. A willing and capable partner who can address these needs may receive favorable government support for their role. To be determined.
Empowering communities and nations with resources to live longer, healthier lives.
